Patents by Inventor Ivan Lopez-Belmonte Encina

Ivan Lopez-Belmonte Encina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions with glycosaminoglycans and use thereof in the treatment of chronic ulcers
    Patent number: 9211305
    Abstract: The invention relates to a composition of glycosaminoglycans for the treatment of diabetic foot ulcer, it specifically relates to low molecular weight heparins (LMWHs) and very low molecular weight heparins (VLMWHs) in the treatment of chronic ulcers, particularly of diabetic foot ulcers, and more specifically in the manufacture of a medicinal product for the treatment of chronic ulcers, and particularly diabetic foot ulcers and pressure ulcers.
    Type: Grant
    Filed: September 5, 2013
    Date of Patent: December 15, 2015
    Assignee: Laboratories Farmaceuticos Roui, S.A.
    Inventors: Ivan Lopez-Belmonte Encina, Maria De Los Angeles Canales Mayordomo, Elena Cebadera Miranda
  • Process for the synthesis of unprotected pentasaccharides from a protected pentasaccharide precursor
    Patent number: 8822659
    Abstract: Procedure for the synthesis of deprotected pentasaccharides from a protected precursor pentasaccharide through a reaction procedure having five stages whereamong is included an N-sulphation of amino groups and a hydrogenolysis of benzyl groups. Through this procedure a drastic reduction is achieved in the total synthesis time in comparison with the process traditionally employed, together with increased reproducibility thereof, permitting the standardization thereof.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: September 2, 2014
    Assignee: Laboratorios Farmacéutios Rovi, S.A.
    Inventors: Ivan Lopez-Belmonte Encina, Rafael Ojeda Martinez De Castilla
  • Pharmaceutical Compositions with Glycosaminoglycans and Use Thereof in the Treatment of Chronic Ulcers
    Publication number: 20140066402
    Abstract: The invention relates to a composition of glycosaminoglycans for the treatment of diabetic foot ulcer, it specifically relates to low molecular weight heparins (LMWHs) and very low molecular weight heparins (VLMWHs) in the treatment of chronic ulcers, particularly of diabetic foot ulcers, and more specifically in the manufacture of a medicinal product for the treatment of chronic ulcers, and particularly diabetic foot ulcers and pressure ulcers.
    Type: Application
    Filed: September 5, 2013
    Publication date: March 6, 2014
    Applicant: LABORATORIOS FARMACEUTICOS ROVI S.A.
    Inventors: Ivan LOPEZ-BELMONTE ENCINA, Maria De Los Angeles CANALES MAYORDOMO, Elena CEBADERA MIRANDA
  • Pharmaceutical dosage forms for the release of active compounds
    Patent number: 8361509
    Abstract: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
    Type: Grant
    Filed: January 23, 2012
    Date of Patent: January 29, 2013
    Assignee: Laboratorios Farmacéticos Rovi, S.A.
    Inventors: Iván López-Belmonte Encina, Ibon Gutierro Aduriz, Philippe Maincent
  • Pharmaceutical forms for the release of active compounds
    Patent number: 8257744
    Abstract: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
    Type: Grant
    Filed: May 13, 2010
    Date of Patent: September 4, 2012
    Assignee: Laboratorios Farmacéuticos Rovi, S.A.
    Inventors: Ivan Lopez-Belmonte Encina, Ibon Gutierro Aduriz, Philippe Maincent
  • Pharmaceutical Dosage Forms for the Release of Active Compounds
    Publication number: 20120189698
    Abstract: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
    Type: Application
    Filed: January 23, 2012
    Publication date: July 26, 2012
    Applicant: LABORATORIOS FARMACEUTICOS ROVI S.A.
    Inventors: Iván LÓPEZ-BELMONTE ENCINA, Ibon GUTIERRO ADURIZ, Philippe MAINCENT
  • PROCESS FOR THE SYNTHESIS OF UNPROTECTED PENTASACCHARIDES FROM A PROTECTED PENTASACCHARIDE PRECURSOR
    Publication number: 20110306757
    Abstract: Procedure for the synthesis of deprotected pentasaccharides from a protected precursor pentasaccharide through a reaction procedure having five stages whereamong is included an N-sulphation of amino groups and a hydrogenolysis of benzyl groups. Through this procedure a drastic reduction is achieved in the total synthesis time in comparison with the process traditionally employed, together with increased reproducibility thereof, permitting the standardisation thereof.
    Type: Application
    Filed: October 2, 2009
    Publication date: December 15, 2011
    Applicant: LABORATORIOS FARMACEUTICOS ROVI, S.A.
    Inventors: Ivan Lopez-Belmonte Encina, Rafael Ojeda Martinez De Castilla
  • PHARMACEUTICAL COMPOSITION WITH GLYCOSAMINOGLYCANS AND USE THEREOF IN THE TREATMENT OF CHRONIC ULCERS
    Publication number: 20110201572
    Abstract: The invention relates to a composition of glycosaminoglycans for the treatment of diabetic foot ulcer, it specifically relates to low molecular weight heparins (LMWHs) and very low molecular weight heparins (VLMWHs) in the treatment of chronic ulcers, particularly of diabetic foot ulcers, and more specifically in the manufacture of a medicinal product for the treatment of chronic ulcers, and particularly diabetic foot ulcers and pressure ulcers.
    Type: Application
    Filed: June 30, 2009
    Publication date: August 18, 2011
    Applicant: LABORATORIOS FARMACEUTICOS ROVI, S.A.
    Inventors: Ivan Lopez-Belmonte Encina, Maria De Los Angeles Canales Mayordomo, Elena Cebadera Miranda
  • Pharmaceutical Forms for the Release of Active Compounds
    Publication number: 20100316722
    Abstract: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
    Type: Application
    Filed: May 13, 2010
    Publication date: December 16, 2010
    Applicant: LABORATORIOS FARMACEUTICOS ROVI S.A.
    Inventors: Iván LOPEZ-BELMONTE ENCINA, Ibon GUTIERRO ADURIZ, Philippe MAINCENT